Book Publication Date:
Jul 2020 Description: This document contains provisions of the merger agreement entered into on January 25, 2009 pursuant to which Pfizer was to acquire Wyeth, two publicly held firms. The provisions relate principally to the stock and cash consideration to be paid by Pfizer, the financing conditions to the transaction and the Termination and Reverse Termination Fees.
Type: Other Document Templates, Contract Clauses
PLI Item #: 41248
Practice Area: Corporate law, Deal structuring, Mergers and acquisitions, Securities and other financial products, Tax, Tender offers